"Narcotic Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents inhibiting the effect of narcotics on the central nervous system.
| Descriptor ID |
D009292
|
| MeSH Number(s) |
D27.505.696.543 D27.505.696.663.850.512 D27.505.954.427.550
|
| Concept/Terms |
Narcotic Antagonists- Narcotic Antagonists
- Antagonists, Narcotic
- Opioid Receptor Antagonists
- Antagonists, Opioid Receptor
- Receptor Antagonists, Opioid
- Opioid Antagonists
- Antagonists, Opioid
|
Below are MeSH descriptors whose meaning is more general than "Narcotic Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Narcotic Antagonists".
This graph shows the total number of publications written about "Narcotic Antagonists" by people in this website by year, and whether "Narcotic Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 1 | 3 |
| 1997 | 4 | 0 | 4 |
| 1998 | 1 | 0 | 1 |
| 1999 | 6 | 0 | 6 |
| 2000 | 5 | 1 | 6 |
| 2001 | 3 | 1 | 4 |
| 2002 | 5 | 3 | 8 |
| 2003 | 0 | 1 | 1 |
| 2004 | 4 | 1 | 5 |
| 2005 | 1 | 1 | 2 |
| 2006 | 6 | 1 | 7 |
| 2007 | 4 | 3 | 7 |
| 2008 | 4 | 1 | 5 |
| 2009 | 5 | 3 | 8 |
| 2010 | 3 | 1 | 4 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 2 | 3 |
| 2013 | 7 | 0 | 7 |
| 2014 | 6 | 1 | 7 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 2 | 3 |
| 2019 | 3 | 3 | 6 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Narcotic Antagonists" by people in Profiles.
-
Medical Student Screening for Naloxone Eligibility in the Emergency Department: A Value-Added Role to Fight the Opioid Epidemic. MedEdPORTAL. 2021; 17:11196.
-
Use of Anticraving Agents in the Treatment of Exhibitionism and Frotteuristic Disorder. J Clin Psychopharmacol. 2021 Sep-Oct 01; 41(5):611-612.
-
Point-of-care naloxone distribution in the emergency department: A pilot study. Am J Health Syst Pharm. 2021 02 08; 78(4):360-366.
-
Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US. JAMA Netw Open. 2020 11 02; 3(11):e2023677.
-
Take-Home Naloxone Program Implementation: Lessons Learned From Seven Chicago-Area Hospitals. Ann Emerg Med. 2020 09; 76(3):318-327.
-
Medical Management of Opioid-Induced Constipation. JAMA. 2019 12 10; 322(22):2241-2242.
-
Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis. Obstet Gynecol. 2019 11; 134(5):921-931.
-
Cold pressor pain and gambling disorder: implications for the opioid system. CNS Spectr. 2020 06; 25(3):426-433.
-
Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose. JAMA Netw Open. 2019 05 03; 2(5):e193209.
-
Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial. Alcohol Alcohol. 2019 Jan 09; 54(5):559-565.